Companies Cryptocurrencies
Protara Therapeutics Inc
Protara Therapeutics Inc
Exchange: NasdaqGS
IPO Date: 22/10/2014
CEO: Mr. Jesse Shefferman
Biotechnology Healthcare 🔗
  • TARA
  • 3.51
  • 39548572
    market cap
  • 0.03999996
If you bought

shares of Protara Therapeutics Inc (TARA) on
You would have made
Old Price $12 Current Price $12

Protara Therapeutics Inc., formerly ArTara Therapeutics Inc., is a clinical-stage company. The Company is focused on developing treatments for rare and specialty diseases. Its development programs focus on the treatment of rare diseases in structural and connective tissues, as well as rare hepatology/gastrointestinal and metabolic disorders. Its product pipeline includes TARA 002 and IV choline chloride for injection. TARA 002 is its lead program focused on the treatment of Lymphatic Malformations (LMs). TARA 002 is a cellular therapy based on OK-432, also known as Picibanil, which is derived from a genetically distinct strain of Streptococcus Pyogenes. IV choline chloride is an enzyme replacement therapy for patients with choline deficiency who exhibit symptoms of liver impairment. IV Choline Chloride is being developed for the treatment of Intestinal Failure Associated Liver Disease (IFALD).

Address: 1 Little West 12Th Street New York City NEW YORK 10014

Stay updated.